Sfoglia per Autore
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors
2012 Zappavigna, S; Luce, A; Panico, A; Porru, M; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts
2012 Porru, M; Zappavigna, S; Luce, A; Panico, A; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO
2013 Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele
Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network.
2013 Pizzi, C; Arpino, G; Acampora, G; Aiello, N; DE Rosa, A; Diaferia, I; DI Nunzio, A; Fragna, G; Franco, A; Russo, M; Sansone, F; Scarpati, C; Spinuso, A; Arpino, G; Luce, A; Tommasielli, G; Caraglia, Michele; DE Placido, S.
Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?
2013 Cucinotto, I; Fiorillo, L; Gualtieri, S; Arbitrio, M; Ciliberto, D; Staropoli, N; Grimaldi, A; Luce, A; Tassone, P; Caraglia, Michele; Tagliaferri, P.
Autophagic cell death: A new frontier in cancer research
2013 Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M.
Basal Cell Carcinoma: Molecular and Pathological Features
2013 Franco, Renato; Anniciello, Am; Botti, G; Caraglia, Michele; Luce, A.
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
2013 Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment?
2013 Franco, Renato; Rocco, G; Marino, Fz; Pirozzi, G; Normanno, N; Morabito, A; Sperlongano, Pasquale; Stiuso, Paola; Luce, A; Botti, G; Caraglia, Michele; ZITO MARINO, Federica
Treatment of c-kit positive adenoid cystic carcinoma of the tongue: A case report.
2014 Mesolella, M; Luce, A; Marino, A; Caraglia, Michele; Ricciardiello, F; Iengo, M.
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans.
2014 Federico, Alessandro; Zappavigna, S; Romano, Marco; Grieco, P; Luce, A; Marra, M; Gravina, Ag; Stiuso, Paola; D’Armiento, Fp; Vitale, G; Tuccillo, C; Novellino, E; Loguercio, Carmelina; Caraglia, Michele
Tuberculous Lymphadenitis in Southern Italy: Clinical Aspects and Treatment Perspectives
2014 Ricciardiello, F; Luce, A; Mesolella, M; Pianese, A; Nappo Quintiliano, S; Oliva, F; Cardone, M; Rizzo, Antonietta; Caraglia, Michele; Leone, C. A.
Keratin 5 expression in squamocellular carcinoma of the head and neck.
2014 Vasca, V; Vasca, E; Freiman, P; Marian, D; Luce, A; Mesolella, M; Caraglia, Michele; Ricciardiello, F; Duminica, T.
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
2014 Franco, Renato; Zappavigna, S; Gigantino, V; Luce, A; Cantile, M; Cerrone, M; Facchini, G; Perdonà, S; Pignata, S; Di Lorenzo, G; Chieffi, Sergio; Vitale, G; DE SIO, Marco; Sgambato, A; Botti, G; Yousif, Am; Novellino, E; Grieco, P; Caraglia, Michele
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid.
2014 Porru, M; Zappavigna, S; Salzano, G; Luce, A; Stoppacciaro, A; Balestrieri, Maria Luisa; Artuso, S; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele
Endocrine disruptors and female cancer: Informing the patients (Review)
2015 Del Pup, Lino; Mantovani, Alberto; Luce, Amalia; Cavaliere, Carla; Facchini, Gaetano; Di Francia, Raffaele; Caraglia, Michele; Berretta, Massimiliano
Temporal bone meningioma involving the middle ear: A case report
2015 Ricciardiello, Filippo; Fattore, Lucia; Liguori, Maria Ester; Oliva, Flavia; Luce, Amalia; Abate, Teresa; Caraglia, Michele; Pianese, Annalisa; Raucci, Aldo Falco
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer
2016 Lombardi, A; Misso, Gabriella; Kawasaki, H; Zappavigna, S; Luce, A; Abate, T; Ferri, C; Cossu, Am; Abate, M; Apa, Ml; Meoli, R; Ricciardiello, F; Caraglia, Michele
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review)
2016 Del Pup, Lino; Mantovani, Alberto; Cavaliere, Carla; Facchini, Gaetano; Luce, Amalia; Sperlongano, Pasquale; Caraglia, Michele; Berretta, Massimiliano
Role of perineural invasion as a prognostic factor in laryngeal cancer
2016 Mesolella, Massimo; Iorio, Brigida; Misso, Gabriella; Luce, Amalia; Cimmino, Mariano; Iengo, Maurizio; Landi, Mario; Sperlongano, Pasquale; Caraglia, Michele; Ricciardiello, Filippo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Zoledronic acid encapsulated in self-assembly pegylated nanoparticles as a new delivery system against brain tumors | 1-gen-2012 | Zappavigna, S; Luce, A; Panico, A; Porru, M; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele | |
Zoledronic acid delivered by self-assembly pegylated nanoparticles has antitumor efficacy against glioblastoma cell lines and xenografts | 1-gen-2012 | Porru, M; Zappavigna, S; Luce, A; Panico, A; Salzano, G; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele | |
NANOPARTICELLE FUNZIONALIZZATE CON TRANSFERRINA ED INCAPSULANTI ACIDO ZOLEDRONICO DETERMINANO INIBIZIONE DELLA CRESCITA DEL GLIOBLASTOMA INTRACRANICO IN VIVO | 1-gen-2013 | Luce, A; Zappavigna, S; Balestrieri, Maria Luisa; D'Onofrio, N; Porru, M; Salzano, G; Lusa, S; Leonetti, C; De Rosa, G; Caraglia, Michele | |
Cancer prevalence in the city of Naples: Contribution of the GP database analyses to the cancer registries network. | 1-gen-2013 | Pizzi, C; Arpino, G; Acampora, G; Aiello, N; DE Rosa, A; Diaferia, I; DI Nunzio, A; Fragna, G; Franco, A; Russo, M; Sansone, F; Scarpati, C; Spinuso, A; Arpino, G; Luce, A; Tommasielli, G; Caraglia, Michele; DE Placido, S. | |
Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time? | 1-gen-2013 | Cucinotto, I; Fiorillo, L; Gualtieri, S; Arbitrio, M; Ciliberto, D; Staropoli, N; Grimaldi, A; Luce, A; Tassone, P; Caraglia, Michele; Tagliaferri, P. | |
Autophagic cell death: A new frontier in cancer research | 1-gen-2013 | Zappavigna, S.; Luce, A.; Vitale, G.; Merola, N.; Facchini, S.; Caraglia, M. | |
Basal Cell Carcinoma: Molecular and Pathological Features | 1-gen-2013 | Franco, Renato; Anniciello, Am; Botti, G; Caraglia, Michele; Luce, A. | |
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC. | 1-gen-2013 | Addeo, R; Zappavigna, Silvia; Luce, Amalia; Facchini, S; Caraglia, Michele | |
Anaplastic lymphoma kinase: a glimmer of hope in lung cancer treatment? | 1-gen-2013 | Franco, Renato; Rocco, G; Marino, Fz; Pirozzi, G; Normanno, N; Morabito, A; Sperlongano, Pasquale; Stiuso, Paola; Luce, A; Botti, G; Caraglia, Michele; ZITO MARINO, Federica | |
Treatment of c-kit positive adenoid cystic carcinoma of the tongue: A case report. | 1-gen-2014 | Mesolella, M; Luce, A; Marino, A; Caraglia, Michele; Ricciardiello, F; Iengo, M. | |
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. | 1-gen-2014 | Federico, Alessandro; Zappavigna, S; Romano, Marco; Grieco, P; Luce, A; Marra, M; Gravina, Ag; Stiuso, Paola; D’Armiento, Fp; Vitale, G; Tuccillo, C; Novellino, E; Loguercio, Carmelina; Caraglia, Michele | |
Tuberculous Lymphadenitis in Southern Italy: Clinical Aspects and Treatment Perspectives | 1-gen-2014 | Ricciardiello, F; Luce, A; Mesolella, M; Pianese, A; Nappo Quintiliano, S; Oliva, F; Cardone, M; Rizzo, Antonietta; Caraglia, Michele; Leone, C. A. | |
Keratin 5 expression in squamocellular carcinoma of the head and neck. | 1-gen-2014 | Vasca, V; Vasca, E; Freiman, P; Marian, D; Luce, A; Mesolella, M; Caraglia, Michele; Ricciardiello, F; Duminica, T. | |
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion. | 1-gen-2014 | Franco, Renato; Zappavigna, S; Gigantino, V; Luce, A; Cantile, M; Cerrone, M; Facchini, G; Perdonà, S; Pignata, S; Di Lorenzo, G; Chieffi, Sergio; Vitale, G; DE SIO, Marco; Sgambato, A; Botti, G; Yousif, Am; Novellino, E; Grieco, P; Caraglia, Michele | |
Medical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acid. | 1-gen-2014 | Porru, M; Zappavigna, S; Salzano, G; Luce, A; Stoppacciaro, A; Balestrieri, Maria Luisa; Artuso, S; Lusa, S; De Rosa, G; Leonetti, C; Caraglia, Michele | |
Endocrine disruptors and female cancer: Informing the patients (Review) | 1-gen-2015 | Del Pup, Lino; Mantovani, Alberto; Luce, Amalia; Cavaliere, Carla; Facchini, Gaetano; Di Francia, Raffaele; Caraglia, Michele; Berretta, Massimiliano | |
Temporal bone meningioma involving the middle ear: A case report | 1-gen-2015 | Ricciardiello, Filippo; Fattore, Lucia; Liguori, Maria Ester; Oliva, Flavia; Luce, Amalia; Abate, Teresa; Caraglia, Michele; Pianese, Annalisa; Raucci, Aldo Falco | |
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer | 1-gen-2016 | Lombardi, A; Misso, Gabriella; Kawasaki, H; Zappavigna, S; Luce, A; Abate, T; Ferri, C; Cossu, Am; Abate, M; Apa, Ml; Meoli, R; Ricciardiello, F; Caraglia, Michele | |
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review) | 1-gen-2016 | Del Pup, Lino; Mantovani, Alberto; Cavaliere, Carla; Facchini, Gaetano; Luce, Amalia; Sperlongano, Pasquale; Caraglia, Michele; Berretta, Massimiliano | |
Role of perineural invasion as a prognostic factor in laryngeal cancer | 1-gen-2016 | Mesolella, Massimo; Iorio, Brigida; Misso, Gabriella; Luce, Amalia; Cimmino, Mariano; Iengo, Maurizio; Landi, Mario; Sperlongano, Pasquale; Caraglia, Michele; Ricciardiello, Filippo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile